ArticleThoracic cancer2020

Superior efficacy of immunotherapy-based combinations over monotherapy for EGFR-mutant non-small cell lung cancer acquired resistance to EGFR-TKIs.

Lu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.